Trials / Completed
CompletedNCT03757611
Efficacy and Safety of Tabetri on Osteoarthritis
A 12 Week, Multi-center, Randomized, Double-blind, Placebo-controlled Clinical Trial for the Evaluation of the Efficacy and Safety of Tabetri on Osteoarthritis
- Status
- Completed
- Phase
- N/A
- Study type
- Interventional
- Enrollment
- 100 (actual)
- Sponsor
- Jaseng Medical Foundation · Academic / Other
- Sex
- All
- Age
- 40 Years – 75 Years
- Healthy volunteers
- Accepted
Summary
This study is a 12-week, multicenter, randomized, double-blind, placebo-controlled clinical trial in order to evaluate the efficacy and safety of tabetri on osteoarthritis.
Detailed description
This study is prospectively conducted to investigate the efficacy and safety of tabetri in patients diagnosed with osteoarthritis at 4 locations of Jaseng Hospital of Korean Medicine (Gangnam, Haeundae, Daejeon, and Bucheon).
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DIETARY_SUPPLEMENT | Tabetri capsule | 1,000 mg/capsule (Taheebo extract 600 mg/day) |
| DIETARY_SUPPLEMENT | Placebo capsule | 1,000 mg/capsule |
Timeline
- Start date
- 2017-07-31
- Primary completion
- 2018-03-13
- Completion
- 2018-06-15
- First posted
- 2018-11-29
- Last updated
- 2018-11-30
Locations
4 sites across 1 country: South Korea
Source: ClinicalTrials.gov record NCT03757611. Inclusion in this directory is not an endorsement.